Xycrobe Therapeutics is a biotechnology company developing microbiome-Based, biotherapeutic delivery systems.
Xycrobe Therapeutics is developing technology that uses microbes (found in the microbiome) as delivery vehicles for biotherapeutics that is headquartered in San Diego, California and was founded in 2014 by Thomas HitchcockThomas Hitchcock. The company aims develop solutions for several clinical indications, with an initial focus on inflammatory skin diseases. Xycrobe Therapeutics research aims to build off the findings of the Human Microbiome Project.